Advanced ovarian cancer patients with no evidence of disease after platinum-based chemotherapy: Retrospective analysis of the role of second-look

European Journal of Gynaecological Oncology

Volumn 20, Issue 1, 1999, Pages 56-60

  Cacciari, N ^a   Zamagni, C ^a   Strocchi, E ^b   Pannuti, F ^a   Martoni, Andrea ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b National Tumor Association   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVARY CANCER; REMISSION; RETROSPECTIVE STUDY; SECOND LOOK SURGERY; TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES;

EID: 0033009666     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Omura G., Blessing J., Ehrlich C. et al.: "A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian cancer". Cancer, 1986, 57, 1725.
2. Curry S., Zembo M., Nahhas W. et al.: "Second-look laparotomy for ovarian cancer". Gvnecol. Oncol., 1981. 11. 114.
3. Berek J., Hacker N., Lagasse L. et al.: "Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status". Obstet. Gynecol., 1984, 64, 207.
4. Dauplat J., Ferriere J. P., Gorbinet M. et al.: "Second-look laparotomy in managing epithelial ovarian cancer". Cancer, 1986, 57, 1627.
5. Clarke-Pearson D., Kohler M., Hurteau J. et al.: "Surgery for advanced ovarian cancer". Clin. Obstet. and Gynecol., 1994, 37, n. 2, 439.
6. Ballon S., Porynuff J., Sikic B. et al.: "Second-look laparotomy in epithelial ovarian carcinoma: precise definition, sensitivity and specificity of the operative procedure". Gynecol. Oncol., 1984, 17, 154.
7. Tuxen M. K., Strauss G., Lund B., Hansen M.: "The role of second-look laparotomy in the long-term survival in ovarian cancer". Annals of Oncol., 1997, 8, 643.
8. Santoro B. T., Griffen W. O., Wangesteen O. H.: "The second-look procedure in the management of ovarian malignancies and pseudomixoma peritonei". Surgery, 1961, 50, 354.
9. Wallach R., Kabakow B., Jerez E. et al.: "The importance of second-look surgical procedures in the staging and treatment of ovarian carcinoma". Seminars in Oncology, 1975, Vol. 2, n. 3.
10. Podratz K., Kinney W. K.: "Second-look operation in ovarian cancer". Cancer, 1993, 71, 1551.
11. Tarraza H., Boyce C., Smith G. et al.: "Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy". Gynecol. Oncol., 1993, 50, 287.
12. Manetta A., MacNeill C., Lyter J. et al.: "Hexamethylmelamine as a single second-line agent in ovarian cancer". Gynecol. Oncol., 1990, 36, 93.
13. Markman M., Hakes T., Reichman B. et al.: "Single agent ifosfamide therapy of ovarian cancer previously treated with cisplatin". Gynecol. Oncol., 1991, 40.
14. Einzig A., Wiernik P., Sasloff J. et al.: "Phase II study and long-term follow-up of patients treated with Taxol for advanced ovarian adenocarcinoma". J. Clin. Oncol., 1992, 10, 1748.
15. Hansen H., Eisenhauer E. A., Hansen M. et al.: "New cytostatic drugs in ovarian cancer". Annals of Oncol., 1993, 4, 63.
16. McGuire W., Hoskins W., Brady M. et al.: "A phase III trial comparing cisplatin/cytoxan and cisplatin/taxol in advanced ovarian cancer. (Meeting abstract)". Proc. Ann. Meet. Am. Soc. Clin. Oncol., 1993, 12, A808.
17. Martoni A., Tomasi L., Farabegoli G. et al.: "4′-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer". Cancer Treat. Rep., 1984, 68, 1391.
18. Martoni A., Bellucco A., Canova N. et al.: "Four-year analysis of platinum and anthracycline combination for ovarian cancer". Oncology, 1989, 46, 109.
19. Martoni A., Ercolino L., Bellucco A. et al.: "Cisplatinum plus epirubicin alternated with cyclophosphamide plus 5-fluprouracil in ovarian cancer". J. Chemother., 1990, Vol. 2. n. 1, 62.
20. Martoni A., Cacciari N., Angelelli B. et al.: "Chemioterapia intraperitoneale nel carcinoma ovarico: esperienza pilota multidisciplinare". Gli Ospedali della vita. 1991, anno XVIII, n. 1, 93.
21. Martoni A., Panetta A., Angelelli B. et at.: "A phase II study of carboplatin and cyclophosphamide in advanced ovarian carcinoma". J. Chemother., 1993, Vol. 5, n. 1, 47.
22. Cacciari N., Martoni A., Zamagni C. et al.: "Analisi dei risultati a lungo termine di regimi di polichemioterapia contenenti cisplatino nel trattamento del carcinoma dell'ovaio in fase avanzata". Acta Oncologica, 1994, Vol. 15, n. 4, 331.
23. Miller A., Hoogstraten B., Staquet M.: "Reporting results of cancer treatment". Cancer, 1981, 47, 207.
24. Hising C., Anjegard I. M., Einhorn N.: "Clinical relevance of the CA 125 assay in monitorins of ovarian cancer patients". Am. J. Clin. Oncol., 1991, 14(2), 111.
25. Murolo C., Costantini S., Foglia G. et al.: "Ultrasound examination in ovarian cancer patients. A comparison with second-look laparotomy". J. Ultrasound Med., 1989, 8, 441.
26. Goldhirsch A., Triller J., Greiner R.: "Computed tomography prior to second-look operation in advanced ovarian cancer". Obstet. Gynecol., 1983, 62, 630.
27. Brenner D., Shaff M., Jones H. et al.: "Abdominopelvic computed tomography: evaluation in patients undergoing second-look laparotomy for ovarian carcinoma". Obstet. Gynecol., 1985, 65, 715.
28. Lund B., Jacobsen K., Rasch L. et al.: "Correlation of abdominal ultrasound and computed tomography scans with second-or third-look laparotomy in patients with ovarian carcinoma". Gynecol. Oncol., 1990. 37, 279.
29. Van der Burg M. E. L.: "More than 20 years second-look surgery in advanced epithelial ovarian cancer: what did we learn?". Annals of Oncol., 1997, 8, 627.
30. Copeland L., Gershenson D.: "Ovarian cancer recurrences in patients with no macroscopic tumor at second-look laparotomy". Obstet. Gynecol., 1986, 68, 873.
31. Podratz K., Schray M., Wieand H. et al.: "Evaluation of treatment and survival after positive second-look laparotomy". Gynecol. Oncol., 1988, 31, 9.
32. Bolis G., Villa A., Guamerio P. et al.: "Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy". Cancer, 1996. 77(1), 128.
33. Podratz, K;, Malkasian G., Hilton J. et al.: "Second-look laparotomy in ovarian cancer: evaluation of pathologic variables". Am. J. Obstet. Gynecol., 1985, 152, 230.
34. Davidson N., Khanna S., Kirwan P. et al.: "Advanced ovarian cancer; long-term results following chemotherapy and second-look laparotomy". Gynecol. Oncol. 1990, 39, 295.
35. Potter M. E.: "Secondary cytoreduction in ovarian cancer: pro or con?". Gynecol. Oncol., 1993, 51, 131.
36. Rubin S., Hoskins W., Saigo P. et al.: "Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy". Gynecol. Oncol., 1991, 42, 137.
37. Segna R., Dottino P., Mandeli J. et al.: "Secondary cytoreduction for ovarian cancer following cisplatin therapy". J. Clin. Oncol. 1993. 11, 434.
38. Wiltshaw E., Raju K. S., Dawson I.: "The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and secondary surgery". Br. J. Obstet. Gynaecol., 1987, 1316.
39. Hoskins P. J., O'Reilly S. E., Swenerton K. D. et al.: "Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy". J. Clin. Oncol., 1992, 10, 1561.
40. Hempling R. E., Wesolowski J. A., Piver M. S.: "Second-look laparotomy in advanced ovarian cancer: a critical assessment of morbidity and impact on survival". Ann. Surg. Oncol., 1997, 4(4), 349.
41. Williams L., Brunetto V. L., Yordan E. et al.: "Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a gynecologic oncology group study". Gynecol. Oncol. 1997, 66(2), 171.
42. Markman M., Reichman B., Hakes T. et al.: "Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer; influence of a prior response to systemic cisplatin". J. Clin. Oncol., 1991, 9, 1801.
43. Markman M.: "Second-look laparotomies in ovarian cancer: a medical oncologist's perspective". J. Cancer Res. Clin. Oncol., 1993, 119(6), 318.
44. Markman M.: "Ovarian cancer update: management challanges and advances". Cleveland Clinic J. Med., 1994, 61(1), 51.
45. Rubin S. C.: "Second-look laparotomy in ovarian cancer. Cancer of the ovary". Edited by Markman M. and Hoskins W. J., Raven Press: 1993, 175.
46. Legros M., Dauplat J., Fleury J. et al.: "High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results". J. Clin. Oncol., 1997, 15, 1302.
47. Stiff P. J., Bayer R., Kerger C. et al.: "High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients". J. Clin. Oncol. 1997, 15, 1309.